[The therapeutic prognosis in chronic evolutive polyarthritis (C.E.P.)].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011565:Psoriasis / Q000150:complications
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone; D001241:Aspirin
Le pronostic thérapeutique dans la polyarthrite chronique évolutive (P.C.E.)